---
title: Formulation Development CDMOs in Canada
path: /services/formulation-development/canada
companies_count: 10
---

# Formulation Development CDMOs in Canada

10 published CDMOs match Formulation Development in Canada.

Locations in this set include Canada, United States, France, Italy, Netherlands, and Poland.

Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Gene Therapy, mRNA, and Biologics (Monoclonal Antibodies).

## Matching companies

- [Altasciences](/companies/altasciences)
  - Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.
- [Applied Pharmaceutical Innovation](/companies/appliedpharma)
  - Edmonton-based not-for-profit offering integrated CDMO services in sterile fill-finish, oral solid dosage, topical application, and highly potent controlled substance manufacturing. Also provides CRO research, regulatory and quality, and clinical and quantitative support.
- [BioVectra](/companies/biovectra)
  - North American CDMO specializing in clinical-to-commercial biologics, small molecules, HPAPIs, and bioreagents with 50+ years of microbial fermentation and complex chemistry expertise across cGMP facilities in Canada.
- [Burrard Pharmaceuticals](/companies/burrardpharma)
  - Vancouver-based CDMO delivering technology transfer, formulation development, and GMP manufacturing for 75+ molecules across oncology, diabetes, and respiratory therapeutics since 2005.
- [Dalton Pharma Services](/companies/dalton)
  - Health Canada–approved and FDA-inspected cGMP contract manufacturer offering integrated drug discovery, development, and manufacturing services including custom synthesis, API production, formulation development, and sterile fill-finish for vials, syringes, and cartridges.
- [Delpharm](/companies/delpharm)
  - Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually.
- [Halo Pharma](/companies/halo-pharma)
  - Halo Pharma provides end-to-end pharmaceutical development and manufacturing for small molecule therapeutics across solids, semi-solids, oral liquids, and sterile injectables, with two North American cGMP facilities and an accelerated 16–20 week tech transfer program.
- [Medicap Laboratories](/companies/medicaplab)
  - Canadian CDMO for advanced oral drug delivery, offering contract manufacturing, pharmaceutical packaging, analytical testing and product development. Proprietary Hypermatrix, PODRAS and nPODDDS platforms target controlled-release and abuse-deterrent products.
- [National Resilience](/companies/resilience)
  - End-to-end CDMO specializing in complex modalities including cell, gene, and RNA-based therapies with North American manufacturing facilities and development capabilities.
- [Northern RNA](/companies/northernrna)
  - Northern RNA is a Calgary, Alberta-based manufacturer of nucleic acids, offering plasmid DNA and mRNA production, chemical manufacturing, and lipid and LNP formulation services. The company also provides analytical and stability testing and development services.